{
    "clinical_study": {
        "@rank": "159884", 
        "acronym": "CoolXenon3", 
        "arm_group": [
            {
                "arm_group_label": "72h cooling + 18h xenon inhalation", 
                "arm_group_type": "Experimental", 
                "description": "Babies in poor condition at birth and referred to our neonatal unit for standard therapy of cooling to 33.5 degree C body temperature will be randomised to receive xenon gas at 50% concentration for 18 hours"
            }, 
            {
                "arm_group_label": "Standard 72 h whole body cooling therapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Whole body cooling therapy to rectal temperature of 33.5 degree Centigrade (standard therapy)"
            }
        ], 
        "brief_summary": {
            "textblock": "This study examines the effect of inhaled xenon gas in the treatment of newborn infants with\n      hypoxic-ischemic encephalopathy (HIE) in combination with cooling, which is the standard\n      treatment for this condition. The hypothesis is that the xenon + cooling combination will\n      produce better neuroprotection than the standard treatment of cooling alone."
        }, 
        "brief_title": "Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth", 
        "completion_date": {
            "#text": "March 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypoxic Ischaemic Encephalopathy", 
        "condition_browse": {
            "mesh_term": [
                "Hypoxia-Ischemia, Brain", 
                "Hypoxia, Brain", 
                "Brain Ischemia", 
                "Ischemia", 
                "Brain Damage, Chronic", 
                "Delirium", 
                "Encephalitis", 
                "Hepatic Encephalopathy", 
                "Neurotoxicity Syndromes", 
                "Brain Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Infants will be eligible for for the trial if the St Michael's hospital standard inclusion\n        criteria for cooling and additional inclusion criteria for xenon administration are met.\n\n        St Michael's hospital standard inclusion criteria for standard hypothermia treatment of 72\n        hrs:\n\n        A: Neonates born at greater than 36 weeks gestation (estimated or clinical assessment)\n        with at least ONE of the following:\n\n          1. Apgar score of \u22645 at ten minutes after birth\n\n          2. Continued need for resuscitation, including tracheal or mask ventilation, at ten\n             minutes after birth\n\n          3. Acidosis, defined as either umbilical cord pH or any arterial, venous or capillary pH\n             within 60 minutes of birth less < 7.00\n\n          4. Base deficit \u226516 mmol/L in umbilical cord blood sample or any blood sample within 60\n             minutes of birth (arterial or venous blood).\n\n        If the infant meets criterion A then assess for neurological abnormality using criterion B\n        and C (by trained personnel):\n\n        B: Moderate or Severe encephalopathy as evidenced by any of the following:\n\n          1. Altered state of consciousness (reduced or absent responses or pathological\n             irritability and hyper responsive and at least ONE or more of the following:\n\n          2. Hypotonia\n\n          3. Abnormal reflexes including oculomotor or pupillary abnormalities\n\n          4. Absent or weak suck\n\n          5. Clinical seizures, as recorded by trained personnel\n\n        And\n\n        C: At least 30 minutes duration of amplitude-integrated electroencephalography (aEEG)\n        recording that shows abnormal background aEEG activity. The decision to cool is based on\n        the worst 30 min section of the aEEG, not the best [35] or seizures (clinical or\n        electrical) thus meeting ONE of the following:\n\n          1. Normal background with some (> 5 min)  electrical seizure activity\n\n          2. Moderately abnormal activity (upper margin of trace >10\u03bcV and lower margin <5\u03bcV)\n\n          3. Suppressed activity (upper margin of trace <10\u03bcV and lower margin of trace <5\u03bcV)\n\n          4. Definite seizure activity\n\n        Additional inclusion criteria for xenon:\n\n        Before being considered for additional inhaled xenon therapy via the breathing gas\n        mixture, the infant would need to meet further additional entry criteria (all must be\n        met):\n\n          1. Intubated, ventilated, sedated, being cooled\n\n          2. \u2264 5 hours old\n\n          3. Any seizures under control\n\n          4. Weight > 2nd centile for gestational age\n\n          5. Stable cardiovascular parameters; Mean arterial pressure >40mmHg.\n\n          6. Oxygen requirement via mechanical ventilator \u2264 40%.\n\n          7. Positive End Expiratory Pressure (PEEP) requirement \u2264 8cm H2O\n\n          8. Arterial (preferable)/capillary/venous pCO2 within acceptable range (<7kPa)\n\n          9. Postnatal age \u2264 5 hours\n\n         10. Absence of major congenital abnormalities, imperforate anus and in particular any\n             bowel obstruction, congenital abnormalities suggestive of chromosomal anomaly or\n             other syndromes that include brain dysgenesis. Congenital syndromes affecting the\n             brain should be excluded when diagnosed.\n\n        Exclusion criteria for cooling in the CoolXenon3 study:\n\n          1. Infants expected to be greater than 3 hours of age at the time of starting cooling\n             treatment.\n\n          2. Futility. Where prognosis is considered to be hopeless e.g. no cardiac output for 20\n             minutes."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "52", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02071394", 
            "org_study_id": "CH/2013/4414", 
            "secondary_id": [
                "2013-004478-80", 
                "13/SW/0300", 
                "CI/2013/0050", 
                "12893/0235/001-0001"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "72h cooling + 18h xenon inhalation", 
                "description": "Inhalation via endotracheal tube of 50% xenon for 18 hours", 
                "intervention_name": "Xenon gas", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "72h cooling + 18h xenon inhalation", 
                    "Standard 72 h whole body cooling therapy"
                ], 
                "description": "Cooling of baby to reduce rectal temperature to 33.5 degree Centigrade(standard treatment)", 
                "intervention_name": "Whole body cooling", 
                "intervention_type": "Other", 
                "other_name": "Therapeutic hypothermia"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Xenon"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Xenon", 
            "Hypothermia", 
            "Hypoxic Ischemic Encephalopathy", 
            "Newborn", 
            "Neonate", 
            "Term", 
            "Neuroprotection", 
            "Cooling", 
            "HIE"
        ], 
        "lastchanged_date": "May 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bristol", 
                    "country": "United Kingdom", 
                    "zip": "BS2 8EG"
                }, 
                "name": "St Michael's Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth: A Randomised Pilot Outcomes Study (COOLXENON3 Study)", 
        "overall_contact": {
            "email": "carol.s.bond@bristol.ac.uk", 
            "last_name": "Marianne Thoresen, Professor", 
            "phone": "+44117 342 5226"
        }, 
        "overall_contact_backup": {
            "email": "carol.s.bond@bristol.ac.uk", 
            "last_name": "Carol Bond", 
            "phone": "+44117 342 5226"
        }, 
        "overall_official": {
            "affiliation": "University of Bristol", 
            "last_name": "Marianne Thoresen, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "United Kingdom: National Health Service", 
                "United Kingdom: Research Ethics Committee"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Comparison of Bayley II neurodevelopment outcome scores between the Cooling plus Xenon treatment group and the standard Cooling only group as assessed by a blinded senior physiotherapist at 18 to 24 months of age.", 
            "measure": "Bayley III neurodevelopmental outcome score", 
            "safety_issue": "No", 
            "time_frame": "18 months to 2 years of age"
        }, 
        "reference": [
            {
                "PMID": "19608817", 
                "citation": "Chakkarapani E, Thoresen M, Hobbs CE, Aquilina K, Liu X, Dingley J. A closed-circuit neonatal xenon delivery system: a technical and practical neuroprotection feasibility study in newborn pigs. Anesth Analg. 2009 Aug;109(2):451-60."
            }, 
            {
                "PMID": "18309163", 
                "citation": "Hobbs C, Thoresen M, Tucker A, Aquilina K, Chakkarapani E, Dingley J. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke. 2008 Apr;39(4):1307-13. Epub 2008 Feb 28."
            }, 
            {
                "PMID": "19142190", 
                "citation": "Thoresen M, Hobbs CE, Wood T, Chakkarapani E, Dingley J. Cooling combined with immediate or delayed xenon inhalation provides equivalent long-term neuroprotection after neonatal hypoxia-ischemia. J Cereb Blood Flow Metab. 2009 Apr;29(4):707-14. Epub 2009 Jan 14."
            }, 
            {
                "PMID": "20658563", 
                "citation": "Chakkarapani E, Dingley J, Liu X, Hoque N, Aquilina K, Porter H, Thoresen M. Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs. Ann Neurol. 2010 Sep;68(3):330-41."
            }, 
            {
                "PMID": "22160201", 
                "citation": "Chakkarapani E, Thoresen M, Liu X, Walloe L, Dingley J. Xenon offers stable haemodynamics independent of induced hypothermia after hypoxia-ischaemia in newborn pigs. Intensive Care Med. 2012 Feb;38(2):316-23. doi: 10.1007/s00134-011-2442-7. Epub 2011 Dec 13."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02071394"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of hours after birth when aEEG voltage has reached a normal or discontinuous normal pattern", 
                "measure": "Amplitude Integrated Electroencephalogram (aEEG) grading", 
                "safety_issue": "No", 
                "time_frame": "Before hospital discharge, usually within 1 week of birth"
            }, 
            {
                "measure": "Brain MRI", 
                "safety_issue": "No", 
                "time_frame": "Before hospital discharge, within 2 weeks of birth"
            }
        ], 
        "source": "United Bristol Healthcare NHS Trust", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Bristol", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "United Bristol Healthcare NHS Trust", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}